Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2002, p. 3848-3850, Vol. 40, No. 10
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.10.3848-3850.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Division of Infectious Diseases,1 Division of Clinical Microbiology, Mayo Clinic and Foundation, Rochester, Minnesota2
Received 9 May 2002/ Returned for modification 6 June 2002/ Accepted 21 June 2002
Studies that detected an association between Streptococcus bovis endocarditis and colon carcinoma have not taken into account the recently identified genetic diversity among organisms historically classified as S. bovis. With near full-length 16S ribosomal DNA sequence analysis, organisms cultured from the blood of endocarditis patients at the Mayo Clinic from 1975 to 1985 and previously identified as S. bovis or streptococcus group D nonenterococci were shown to represent S. bovis biotypes I (11 isolates) and II/2 (1 isolate), S. salivarius (1 isolate), and S. macedonicus (1 isolate). Two of the S. bovis biotype I cases were associated with colon cancer. Whether S. bovis biotype II or other organisms closely related to and historically identified as S. bovis (e.g., S. macedonicus) are associated with malignant (or premalignant) colon lesions in humans remains to be definitively determined.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»